Does Residential Mobility Affect Childhood Leukemia?April 22, 2019Leukemia, Myelodysplasia, Transplantation
Study highlights lack of data on transgender leukemia patientsApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationHematology
ALF 2019 showcases evolving treatment of AMLApril 19, 2019AMLLeukemia, Myelodysplasia, Transplantation
Creating CAR T-cell therapies for T-cell malignanciesApril 16, 2019Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Gilteritinib prolonged survival in FLT3-mutated AMLApril 12, 2019AMLLeukemia, Myelodysplasia, Transplantation
Bendamustine/rituximab combo proves viable for comorbid CLLApril 10, 2019Leukemia, Myelodysplasia, Transplantation
Ibrutinib sustained responses in refractory CLL in long-term follow-upMarch 27, 2019Leukemia, Myelodysplasia, Transplantation
Anti-CD45 conditioning looks safe, feasible in relapsed AMLMarch 13, 2019AMLLeukemia, Myelodysplasia, Transplantation
Immunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019OncologyMelanomaLeukemia, Myelodysplasia, Transplantation
Obinutuzumab-based regimens yield durable remissions in CLLJanuary 16, 2019Leukemia, Myelodysplasia, Transplantation
ALL chemotherapy looks effective in mixed phenotype leukemiaJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationHematology
Older CLL Patients See Better PFS With IbrutinibDecember 6, 2018Leukemia, Myelodysplasia, Transplantation
In IDH-mutated AML, first-line IDH inhibitors plus chemo may boost remissionDecember 5, 2018AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Beat AML trial delivers genomic results in 7 daysDecember 2, 2018AMLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Gut bacteria influence HCT outcomesDecember 2, 2018Leukemia, Myelodysplasia, TransplantationOncologyHematology
